Nura Bio (formerly Proneurotech) Launches to Discover and Develop Neuroprotective Drugs, Backed by $73M Series A Financing Portfolio News / Karina Tin July 29, 2020 Nura Bio (formerly Proneurotech) Launches to Discover and Develop Neuroprotective Drugs, Backed by $73M Series A Financing Read More »
NGM Bio Announces Initiation of Phase 2 CATALINA Study of NGM621 in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) Portfolio News / Karina Tin July 27, 2020 NGM Bio Announces Initiation of Phase 2 CATALINA Study of NGM621 in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) Read More »
Nurix Therapeutics Announces Pricing of $209 Million Initial Public Offering Portfolio News / Karina Tin July 23, 2020 Nurix Therapeutics Announces Pricing of $209 Million Initial Public Offering Read More »
Circle Pharma Appoints Rajinder Singh, PhD as its Chief Science Officer Portfolio News / Karina Tin July 20, 2020 Circle Pharma Appoints Rajinder Singh, PhD as its Chief Science Officer Read More »
Arcus Biosciences and Gilead Sciences Complete Closing of Their 10-Year Partnership to Co-Develop and Co-Commercialize Next-Generation Cancer Immunotherapies Portfolio News / Karina Tin July 13, 2020 Arcus Biosciences and Gilead Sciences Complete Closing of Their 10-Year Partnership to Co-Develop and Co-Commercialize Next-Generation Cancer Immunotherapies Read More »
Revolution Medicines Announces Pricing of $156.0 Million Public Offering of Common Stock Portfolio News / Karina Tin July 8, 2020 Revolution Medicines Announces Pricing of $156.0 Million Public Offering of Common Stock Read More »
Arcus Biosciences Appoints Bob Goeltz as Chief Financial Officer Portfolio News / Karina Tin July 7, 2020 Arcus Biosciences Appoints Bob Goeltz as Chief Financial Officer Read More »